Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases (Q79756999)
Jump to navigation
Jump to search
scientific article published on 30 October 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases |
scientific article published on 30 October 2008 |
Statements
Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases (English)
P Chevallier
N Robillard
G Houille
S Ayari
T Guillaume
J Delaunay
J-L Harousseau
M Mohty
30 October 2008